SCHEMBL27286643

SCHEMBL27286643

CC1(C)CN(CI)CCO1

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PLAT P00750 1/20 0.30
PDE10A Q9Y233 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3478179 0.80 TSHR (0.32) PLATPDE10A
SCHEMBL16107050 0.79 PLAT (0.32) PLAT
SCHEMBL5363378 0.78 PLAT (0.30) PLATPDE10A
SCHEMBL4550374 0.77 KDM4E (0.33) PLAT
SCHEMBL2073495 0.75 KDM4E (0.45)
SCHEMBL16040668 0.75 PDE7B (0.32)
SCHEMBL9801410 0.75 ALOX15 (0.41)
SCHEMBL18599103 0.75 PDE10A (0.31) PDE10A
SCHEMBL3419943 0.75 MGLL (0.41)
SCHEMBL25785338 0.74 MGLL (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024015851-A1 TREATMENT OF CELL PROLIFERATION-ASSOCIATED CONDITIONS USING A COMBINATION OF A CLB-B INHIBITOR AND AN ADDITIONAL THERAPEUTIC AGENT HOTSPOT THERAPEUTICS, INC. (US) 2024-01-18 WO disclosed